TCTR20210524001尚未招募4 期
Change of OCT findings after Intravitreal Anti-VEGF injection in patients with diabetic tractional retinal detachment : A Randomized Controlled Trial
Research Funds, Faculty of medicine, KK0 个研究点目标入组 80 人开始时间: 2021年5月24日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •1. Age > 18 years
- •2. With the following characteristics
- •2.1) underlying disease of type 1 or type 2 diabetes mellitus
- •2.2) diagnosed with PDR with TRD requiring surgery
- •2.3) OCT scans on the enroll day with good interpretable quality showing fibrous traction on preretinal area and tractional retinal detachment
- •2.4) If two eyes are elligible, only one eye per patient (the eye with worse visual acuity) will be included in the study.
排除标准
- •1. Patient with center-involved DME with macular edema from component other than traction
- •2. Patient with severe anterior segment pathology precluding OCT scans, fundus examination (i.e. dense cataract, dense vitreous hemorrhage)
- •3. Previous intraocular surgery (except uncomplicated cataract surgery)
- •4. Previous Injection into study eyes within 6 months
- •5. Patient contraindicated to intravitreal injection (i.e endophthalmitis)
- •6. Patient with other ocular pathology causing possible neovascularization, retinal detachment or fibrous traction in study eyes (Traumatic retinal detachment, Uveitis, Retinal vascular disease, Congenital vitreoretinopathy
- •7. Patient denied intravitreal injection
研究者
相似试验
已完成
3 期
Retinal DiseaseCTRI/2018/04/012952Giridhar Eye Institute18
Unknown
3 期
Intravitreal injection versus medical treatment for acute CSREye DiseasesPACTR202204601902304Suez Canal University Hospital45
尚未招募
不适用
Effect of Alternate Treatment with Intravitreal Anti-Vascular Endothelial Growth Factor and Corticosteroid for Macular EdemaKCT0007766Hallym University Medical Center-Kangnam188
已完成
不适用
Comparison of treatment response to intravitreal injection of triamcinolone, bevacizumab and combined form in patients with Central Retinal Vein Occlusion : A Randomized Clinical Trialthe efficacy of triamcinolone and bevacizumabwas measured in patients with Central Retinal Vein OcclusionBevacizumab,Intravitreal Injections,Retinal Vein Occlusion,TriamcinoloneTCTR20170612005rmia university of medical sciences90
进行中（未招募）
不适用
Optical Coherence Tomography Angiography Biomarkers in a Bi-monthly Maintenance Dosing Aflibercept in Patients with Neovascular Age-Related Macular DegeneratioDiseases of the eye and adnexaKCT0007375Kyung Hee University Hospital40